Interbody vs Instrumented Posterolateral Fusion Following Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis

August 17, 2018 updated by: The London Spine Centre

Interbody Fusion and Decompression Versus Instrumented Posterolateral Fusion and Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis

Degenerative spondylolisthesis describes the slip of one spinal segment relative to the adjacent segment. It is usually associated with spinal stenosis (which limits one's ability to walk and stand) and is the most common indication for surgery in adults over age 65 years. A variety of surgical techniques are available; the most common are the Posterolateral Instrumented Fusion (PLF), and Interbody Fusion (IF) including Posterolateral Interbody Fusion (PLIF), and Transforaminal Interbody fusion (TLIF). IF uses a cage that is placed within the cleaned out disc space between the vertebral bodies being fused. Although this approach achieves a good fusion rate and deformity correction it is associated with a higher surgical cost and potential intra-operative complication rate. What is more, no consensus exists as to whether IF provides better patient rated functional outcome and quality of life. If the advantages of IF do not translate into superior patient rated outcomes, then the risk-benefit ratio would be tipped in favor of PLF. The purpose of this study is to determine if IF is equivalent to PLF for the treatment of degenerative spondylolisthesis. The investigators will conduct a prospective randomized control trial comparing these two procedures. Our primary outcome measure will be the Oswestry Disability Index, which evaluates spinal pain and function.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

178

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • London, Ontario, Canada, N6G 5L7
        • Recruiting
        • London Health Sciences Centre
        • Contact:
        • Principal Investigator:
          • Christopher S Bailey, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients aged 50 years or older
  2. Grade I or II (less than 50% slip of the cephalad vertebra compared to the caudal vertebra) degenerative spondylolisthesis at one or two contiguous levels between L1 and L5.
  3. Lumbar spinal stenosis at the same levels of the degenerative spondylolisthesis producing radiculopathy or neurogenic claudication unresponsive to a minimum of 3 months of non surgical treatment
  4. Patients who are medically suitable for surgical management
  5. Patients who have consented for surgical treatment
  6. Patients able to provide informed consent for the study and complete the questionnaires

Exclusion Criteria:

  1. Lytic spondylolisthesis
  2. Non degenerative stenosis (example: tumor, trauma, epidural lipomatosis)
  3. Severe vertical foraminal stenosis necessitating interbody insertion to re-establish foraminal height
  4. Segmental kyphosis at the level of the spondylolisthesis
  5. Segmental scoliosis >10 degrees at the level of the spondylolisthesis
  6. Rheumatoid arthritis
  7. Active infection
  8. On long term disability or workers compensation claim
  9. Drug or alcohol misuse
  10. Lack of permanent home residence
  11. Previous surgery at the proposed surgical level
  12. Previous fusion in the lumbar spine
  13. Contraindication to surgery: medical co morbidities
  14. Unable to complete questionnaire (e.g. Dementia)
  15. Unable to give voluntary consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Interbody Fusion
The interbody fusion (IF) procedure requires exposure and removal of the disc, curetting the end plates, inserting a cage filled with bone graft, as well as stabilization with rods and screws.
Other Names:
  • Posterolateral Interbody Fusion (PLIF)
  • Transforaminal Interbody fusion (TLIF)
Active Comparator: Posterolateral Fusion
In posterolateral fusion stabilization is achieved using pedicle screws joined by rods. The graft used to facilitate fusion is placed between decorticated transverse processes and can be an autograft of iliac bone or local bone, allograft, or a synthetic expander.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Disability Index
Time Frame: 1 year post surgery
The Oswestry Disability Index is an effective method of measuring disability in patients with back and leg pain and is well suited to patients who have had persistent severe disability. It is a commonly utilized, validated, and highly reproducible. The questionnaire can be completed in less than 5 minutes and a large amount of normative data exists.
1 year post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Disability Index
Time Frame: Enrollment, and at 6 weeks, 3 months, 6 months, 2 years, 5 years and post surgery
The Oswestry Disability Index is an effective method of measuring disability in patients with back and leg pain and is well suited to patients who have had persistent severe disability. It is a commonly utilized, validated, and highly reproducible. The questionnaire can be completed in less than 5 minutes and a large amount of normative data exists.
Enrollment, and at 6 weeks, 3 months, 6 months, 2 years, 5 years and post surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale for back pain intensity (0-10: 0= no pain, 10=worst pain)
Time Frame: Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Visual Analogue Scale for leg pain intensity (0-10: 0= no pain, 10=worst pain)
Time Frame: Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
SF-12 (General Health outcome measure)
Time Frame: Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
The SF-12 is a standardized health related quality of life outcome questionnaire, which assess 8 health domains. The physical and mental component can be derived. It has been shown to be valid and reliable when applied to the spine patient population.
Enrollment at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Patient satisfaction
Time Frame: Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
"All things considered, how satisfied are you with the results of your recent treatment for your spine fracture? 1-7, 8= not sure." This sentence is the recommended tool for assessing global satisfaction.
Enrollment and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Cost analysis
Time Frame: Enrollment, and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Prolo economic score and cost analysis for each procedure
Enrollment, and at 6 weeks, 3 months, 6 months, 1 year, 2 year, 5 year post surgery
Fusion rates
Time Frame: 6 months, 1 year, 5 year
6 months, 1 year, 5 year
Intra-operative Complication rate
Time Frame: within 6 weeks after sugery
within 6 weeks after sugery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher S Bailey, MD, The London Spine Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2013

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

August 9, 2013

First Submitted That Met QC Criteria

August 12, 2013

First Posted (Estimate)

August 13, 2013

Study Record Updates

Last Update Posted (Actual)

August 20, 2018

Last Update Submitted That Met QC Criteria

August 17, 2018

Last Verified

August 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Stenosis

Clinical Trials on Interbody Fusion

3
Subscribe